Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus

被引:69
作者
Serwadda, D
Wawer, MJ
Shah, KV
Sewankambo, NK
Daniel, R
Li, CJ
Lorincz, A
Meehan, MP
Wabwire-Mangen, F
Gray, RH
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21205 USA
[2] Makerere Univ, Inst Publ Hlth, Kampala, Uganda
[3] Makerere Univ, Dept Med, Kampala, Uganda
[4] Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda
[5] Columbia Univ, Sch Publ Hlth, Ctr Populat & Family Hlth, New York, NY USA
[6] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol, Baltimore, MD 21205 USA
[7] Digene Corp, Silver Spring, MD USA
关键词
D O I
10.1086/315026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A random sample of 960 women aged 15-59 years enrolled in a population-based study in rural Uganda were asked to provide self-collected vaginal swabs for human papillomavirus (HPV) testing by hybrid capture assay. The intensity of HPV infection was assessed by the relative light unit (RLU) ratio in the specimen-to-positive control (PC) ratio. In total, 898 women (93%) provided a swab and 737 provided serum for human immunodeficiency virus type 1 (HIV-1) determination, HPV prevalence was 16.7% and was highest in younger women. HIV-1 prevalence was 17.8%. HPV prevalence was 44.3% in HIV-positive and 10.2% in HIV-negative women (rate ratio, 5.36; 95% confidence interval, 3.81-7.54). The intensity of HPV infection was significantly greater among HIV-positive than HIV-negative women (54.4 vs. 11.1 RLU/PC; P = .026); intensity of infection was highest in women aged <30 years. The higher prevalence and intensity of HPV infection in HIV-positive women could facilitate HPV transmission in this population, Self-collected vaginal swabs could be used in population-based screening to identify women at high risk of cervical neoplasia.
引用
收藏
页码:1316 / 1319
页数:4
相关论文
共 15 条
[1]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[2]  
HILL R, 1997, 16 INT HUM PAP C SIE
[3]  
Lorincz AT, 1996, OBSTET GYN CLIN N AM, V23, P707
[4]  
LUNT R, 1984, OBSTET GYNECOL, V63, P708
[5]   COMPARISON BETWEEN METHODS FOR HUMAN PAPILLOMAVIRUS DNA TESTING - A MODEL FOR SELF-TESTING IN YOUNG-WOMEN [J].
MOSCICKI, AB .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) :723-725
[6]  
PISANI P, 1985, INT J CANCER, V55, P891
[7]   STRATEGIES FOR GLOBAL CONTROL OF CERVICAL-CANCER [J].
PONTEN, J ;
ADAMI, HO ;
BERGSTROM, R ;
DILLNER, J ;
FRIBERG, LG ;
GUSTAFSSON, L ;
MILLER, AB ;
PARKIN, DM ;
SPAREN, P ;
TRICHOPOULOS, D .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (01) :1-26
[8]   NEW EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL NEOPLASIA [J].
SCHIFFMAN, MH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18) :1345-1347
[9]  
SELLORS JW, 1997, 16 INT PAP C SIEN IT
[10]   Human papillomavirus infection in women infected with the human immunodeficiency virus [J].
Sun, XW ;
Kuhn, L ;
Ellerbrock, TV ;
Chiasson, MA ;
Bush, TJ ;
Wright, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1343-1349